Ads
related to: Eagle Pharmaceuticals Inc
Search results
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoEagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q4 2022 Earnings Call Transcript March 13, 2023 Operator:...
Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Stock Has Shown Weakness Lately But Financial Prospects...
Simply Wall St. via Yahoo Finance· 2 years agoEagle Pharmaceuticals (NASDAQ:EGRX) has had a rough three months with its share price down 14%. But...
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Stock Is Going Strong But Fundamentals Look Uncertain:...
Simply Wall St. via Yahoo Finance· 9 months agoEagle Pharmaceuticals (NASDAQ:EGRX) has had a great run on the share market with its stock up by a...
Can Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Performance Keep Up Given Its Mixed Bag Of...
Simply Wall St. via Yahoo Finance· 1 year agoEagle Pharmaceuticals' (NASDAQ:EGRX) stock is up by 8.7% over the past three months. However, the...
Time To Worry? Analysts Are Downgrading Their Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Outlook
Simply Wall St. via Yahoo Finance· 2 years agoThe latest analyst coverage could presage a bad day for Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX),...
Industry Analysts Just Made A Substantial Upgrade To Their Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)...
Simply Wall St. via Yahoo Finance· 2 years agoShareholders in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) may be thrilled to learn that the analysts...
Enalare Secures BARDA Award Of $50M For ENA-001 In Drug Overdose
Benzinga via Yahoo Finance· 2 years agoEagle Pharmaceuticals Inc (NASDAQ: EGRX) announced that Enalare Therapeutics Inc secured a contract...
Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player
Benzinga via Yahoo Finance· 2 years agoEagle Pharmaceuticals Inc (NASDAQ: EGRX) has agreed to make a $25 million equity investment in...
A Look At The Intrinsic Value Of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights The projected fair value for Eagle Pharmaceuticals is US$20.05 based on 2 Stage Free...
Investors in Eagle Pharmaceuticals (NASDAQ:EGRX) have unfortunately lost 50% over the last three...
Simply Wall St. via Yahoo Finance· 2 years agoEagle Pharmaceuticals, Inc. (NASDAQ:EGRX) shareholders should be happy to see the share price up 20%...
Ad
related to: Eagle Pharmaceuticals Inc